Conferences  >  Informatics  >  Implementation and Applications of Artificial Intelligence  >  Spain

Allan Lloyds Group

The 3rd Annual Pharma Commercial Excellence Summit is a senior-level industry forum taking place on 25–26 March 2026 in Madrid, bringing together C-level executives, senior vice presidents, and commercial leaders from leading pharmaceutical organisations to focus on practical commercial transformation and measurable impact. The 2026 edition centres on the transition from digital adoption to AI-enabled commercial decision-making, addressing how artificial intelligence, analytics, CRM, automation, and omnichannel capabilities are embedded into go-to-market models to improve execution speed, simplify operational complexity, strengthen data governance and compliance, and drive sustainable enterprise value. Through real-world case studies and peer-level discussions, the summit explores AI-driven launch excellence, commercial process automation, portfolio and field force optimisation, customer engagement strategy, and the redesign of commercial operating models, leadership, and capabilities in AI-enabled organisations.

Phone: [+421 2 21 021 348 ext:470];     Email: vladyslava.malenta@alloydsevents.com

Pharma commercial excellence, AI in pharmaceuticals, Go-to-Market strategy, Commercial transformation, CRM optimisation, Omnichannel engagement, Sales force effectiveness, Launch excellence, Customer experience, Data governance and compliance, Commercial operations, Process automation, Field force optimisation, Business insights and analytics, Leadership in AI-enabled organisations

Regulation in Medicine and Pharmacology,    Neural Networks and Artificial Intelligence, Machine Learning

IADIS

Although the term Artificial Intelligence (AI) was coined in the 1950´s, more recently, it has been at the centre of unprecedented attention. Developments in AI technology have created much interest from all areas of society, such as Education, Business and Health. The benefits of deploying AI are being reported transversally in all sectors. Nonetheless, AI’s potential evolves hand in hand with unyielding concerns that cause restraint and limit its widespread use. The International Conference on Artificial Intelligence in Society (AIS) aims to reunite both researchers and practitioners in addressing AI most pressing questions.

Conference Secretariat;     Email: secretariat@aisociety-conf.org

Artificial Intelligence, Core AI Research and Methodologies, Machine learning and deep learning advances, Natural language processing and multimodal AI, Reinforcement learning and autonomous systems, Explainable and interpretable AI, Human-in-the-loop and hybrid intelligence systems, Edge and distributed AI architectures, AI and Security, Chatbots and virtual assistants, AI in Education, AI in Healthcare, AI in Business, Industry, and Economics, AI for the Progress of Society, AI Ethics and Legislation/Regulation